Clinical Evidence: Several studies support the potential of BPC-157 in correcting calcium imbalance: a) A study published in the Journal of Orthopaedic Research demonstrated that BPC-157 administration improved bone healing and increased calcium deposition in rats with induced bone fractures, suggesting its positive effect on calcium metabolism
They also offer more controllable results, making them more ideal for precise enhancements like the lips, and PRF more suitable for broader areas, such as tear troughs
Biohacking culture People want to optimize performance and longevity Social media influence Peptides are widely promoted as recovery shortcuts Frustration with slow healing = lack of education by providers on how long tendon/ligament injuries can take to repair Athletes often seek ways to speed recovery beyond natural timelines A Major Concern: Unregulated Products Currently: most peptides are not approved by Health Canada or the FDA manufacturing is largely unregulated quality control is inconsistent This makes it difficult to verify: product purity dosing accuracy contamination risk Current Medical Consensus Peptides show biological promise in preclinical research but lack sufficient human evidence for routine clinical use Important unknowns include: dosing frequency duration long-term safety How Group23 Approaches Regenerative Medicine At Group23 Sports Medicine, we focus on treatments supported by the strongest evidence: structured rehabilitation programs under physiotherapy supervision load management and strength training ideally with strength and conditioning coach platelet-rich plasma (PRP) soft tissue adapted biocompatible hyaluronic acid injections SportVis see www.sportvis.ca high molecular weight cross linked hyaluronic acid injections Monovisc (see www.monovisc.ca), Synolis VA (see www.synolis.com) and Durolane (www.durolane.ca/en/) Blood Flow Restriction (BFR) therapy (see off the shelf and custom bracing strategies These treatments currently have far stronger clinical evidence than experimental peptide therapies
People have different opinions about this
You must bill their medical plan
Methionine acts as a lipotropic agent, helping to break down fats in the liver
